treatment of skeletal muscle conditions. Each of the indications for Onabotulinumtoxin A®
use have adverse events reported in the past. The aim of this study was to review dverse
events in children less than 2 years of age who were treated with Onabotulinumtoxin A®
injections as part of equinus foot deformity, in the setting of clubfoot at British Columbia's
Children Hospital. Methods A retrospective review of all clubfoot patients at British …